Is Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Ready for "Prime Time"?
- PMID: 25465339
- PMCID: PMC4470869
- DOI: 10.1016/j.eururo.2014.11.027
Is Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Ready for "Prime Time"?
Comment on
-
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.Eur Urol. 2015 Jul;68(1):8-19. doi: 10.1016/j.eururo.2014.10.026. Epub 2014 Nov 1. Eur Urol. 2015. PMID: 25454618 Review.
References
-
- Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, Mozer P, Rastinehad AR, Ahmed HU. The Detection of Clinically Significant Prostate Cancer using MRI to Ultrasound Fusion Targeted Biopsy: a Systematic Review. Eur Urol. 2014 (in press). - PubMed
-
- de Rooij M, Crienen S, Witjes JA, Barentsz JO, Rovers MM, Grutters JP. Cost-effectiveness of Magnetic Resonance (MR) Imaging and MR-guided Targeted Biopsy Versus Systematic Transrectal Ultrasound-Guided Biopsy in Diagnosing Prostate Cancer: A Modelling Study from a Health Care Perspective. European urology. 2013 - PubMed
-
- Wysock JS, Rosenkrantz AB, Huang WC, Stifelman MD, Lepor H, Deng FM, et al. A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging-Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial. European urology. 2013 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical